Transamerica Financial Advisors LLC purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 16,868 shares of the company’s stock, valued at approximately $2,172,000.
Other institutional investors have also modified their holdings of the company. Gables Capital Management Inc. purchased a new position in shares of Merck KGaA in the 2nd quarter worth approximately $2,095,000. Diversify Advisory Services LLC bought a new position in shares of Merck KGaA during the 2nd quarter worth approximately $3,810,000. Danske Bank A S purchased a new stake in Merck KGaA during the second quarter valued at approximately $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new stake in Merck KGaA during the second quarter valued at approximately $25,541,000. Finally, BOK Financial Private Wealth Inc. acquired a new stake in Merck KGaA in the second quarter valued at approximately $523,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Price Performance
OTCMKTS MKGAF opened at $164.58 on Thursday. The firm’s fifty day simple moving average is $163.19 and its two-hundred day simple moving average is $148.83. The firm has a market capitalization of $21.27 billion, a P/E ratio of 25.13 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
